Degree of diabetic neuropathy and glucosylated hemoglobin in diabetic patients, in the Family Medical Unit 62

Abstract

Background: Diabetic neuropathy is damage to nerve fibers derived from chronic hyperglycemia. In Mexico, 60% with type 2 diabetes mellitus have diabetic neuropathy and its frequency depends on the duration of diabetes. It is a cause of mortality and morbidity. since 50% of cases develop non-traumatic amputations. For this reason, my objective is to estimate the association between the degree of diabetic neuropathy and hemoglobin glycosylase. Methods: An observational, cross-sectional, prolective, analytical study was carried out in a sample of 154 patients, through non-probabilistic, non-randomized convenience sampling. Patients with a diagnosis of type 2 diabetes from the UMF 62 were included, applying the Semmens-Weinstein Test for the diagnosis of diabetic neuropathy with sensitivity of 97% and specificity of 83%, subsequently the degree of neuropathy was evaluated through the instrument. of Michigan with sensitivity of 79% and specificity of 94%, descriptive statistics were performed and in a second moment the Kruskall-Wallis ANOVA test with a (p=<0.05). Results: It was found that of the 154 patients, 3.8% remained in control and 16.23% (25 patients) remained uncontrolled, presenting grade 1 neuropathy, in grade 2 diabetic neuropathy 7.14% (11 patients) were within goals and the 72.72%, (112 patients) in lack of control, no patients with grade 3 neuropathy were obtained, it was evident that 89.02% are in lack of glycemic control and with peripheral sensory complications. It was found that there was no association between these two variables (p= 0.452).

Conclusions: It was concluded that in the Michigan Neuropathy test, in patients without amputations or Charcot's foot, it is not possible to stage severe neuropathy, so patients with amputations and musculoskeletal alterations in the feet must be included as an inclusive criterion.